- Report
- February 2024
- 100 Pages
China
From €1739EUR$1,800USD£1,487GBP
- Report
- February 2024
- 71 Pages
China
From €1739EUR$1,800USD£1,487GBP
- Report
- February 2024
- 221 Pages
China
From €3864EUR$4,000USD£3,304GBP
The Anti Dermatomycosis Drug market is a subset of the Dermatological Drugs market, which includes drugs used to treat skin conditions. Anti Dermatomycosis Drugs are used to treat fungal infections of the skin, such as athlete's foot, ringworm, and jock itch. These drugs are typically topical, and can be applied directly to the affected area. They may also be taken orally, depending on the severity of the infection. Common active ingredients in Anti Dermatomycosis Drugs include clotrimazole, miconazole, and terbinafine.
Some companies in the Anti Dermatomycosis Drug market include GlaxoSmithKline, Novartis, Pfizer, Merck, and Bayer. Show Less Read more